RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Shareholder Structure

Home  >  Investor Relations  >  Stock Information  >  Shareholder Structure

QIAGEN attaches great value to close contacts with its shareholders. On September 14, 2021, QIAGEN submitted a request for shareholder identification in accordance with section 49b of the Dutch Giro Securities Act (Wet giraal effectenverkeer), with a reference date of September 13, 2021. The requested information must be received by QIAGEN by September 24, 2021, at the latest. A shareholder who, alone or together with other shareholders, represents at least one/hundredth of QIAGEN's issued share capital, or is entitled to QIAGEN shares with an aggregate amount of EUR 250,000 on the reference date September 13, 2021, may submit a written request for information obtained via the shareholder identification to QIAGEN.

Name Holdings % Stake
BlackRock, Inc. 33,800,666 14.64
Sun Life Financial, Inc. (MFS) 21,010,688 9.10
State Street Corp. 7,628,807 3.30
Goldman Sachs & Co. LLC 7,063,376 3.06

Status: August 27, 2021

Source: QIAGEN Shareholder ID
Source: QIAGEN Shareholder ID